Cargando…

Synergistic treatment of osteosarcoma with biomimetic nanoparticles transporting doxorubicin and siRNA

INTRODUCTION: Osteosarcoma tumors are the most common malignant bone tumors in children and adolescents. Their treatment usually requires surgical removal of all detectable cancerous tissue and multidrug chemotherapy; however, the prognosis for patients with unresectable or recurrent osteosarcoma is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Jingtong, Mu, Xupeng, Hou, Xuejia, Zhang, Xiaowen, Li, Ping, Jiang, Jinlan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900173/ https://www.ncbi.nlm.nih.gov/pubmed/36756155 http://dx.doi.org/10.3389/fonc.2023.1111855

Ejemplares similares

Dual Targeted Nanoparticles for the Codelivery of Doxorubicin and siRNA Cocktails to Overcome Ovarian Cancer Stem Cells
por: Chen, Li, et al.
Publicado: (2023)

Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapy
por: Butowska, Kamila, et al.
Publicado: (2023)

Effective Delivery of siRNA-Loaded Nanoparticles for Overcoming Oxaliplatin Resistance in Colorectal Cancer
por: Zhou, Yue, et al.
Publicado: (2022)

siRNA Knockdown of RRM2 Effectively Suppressed Pancreatic Tumor Growth Alone or Synergistically with Doxorubicin
por: Zheng, Shuquan, et al.
Publicado: (2018)

Corrigendum: Effective Delivery of siRNA-Loaded Nanoparticles for Overcoming Oxaliplatin Resistance in Colorectal Cancer
por: Zhou, Yue, et al.
Publicado: (2022)

Doxorubicin Delivered Using Nanoparticles Camouflaged with Mesenchymal Stem Cell Membranes to Treat Colon Cancer
por: Liu, Yi, et al.
Publicado: (2020)

Quick synthesis of a novel combinatorial delivery system of siRNA and doxorubicin for a synergistic anticancer effect
por: Chen, Mengchun, et al.
Publicado: (2019)

Enzyme-triggered PEGylated siRNA-nanoparticles for controlled release of siRNA
por: Yingyuad, Peerada, et al.
Publicado: (2014)

Advances in siRNA therapeutics and synergistic effect on siRNA activity using emerging dual ribose modifications
por: Gangopadhyay, Sumit, et al.
Publicado: (2022)

Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy
por: Xia, Yu, et al.
Publicado: (2017)

Redox/pH-Responsive 2-in-1 Chimeric Nanoparticles for the Co-Delivery of Doxorubicin and siRNA
por: Wu, Hsi-Chin, et al.
Publicado: (2021)

PD-L1 siRNA Theranostics With a Dextran Nanoparticle Highlights the Importance of Nanoparticle Delivery for Effective Tumor PD-L1 Downregulation
por: Pacheco-Torres, Jesus, et al.
Publicado: (2021)

Polydopamine Nanoparticles Camouflaged by Stem Cell Membranes for Synergistic Chemo-Photothermal Therapy of Malignant Bone Tumors
por: Zhang, Meng, et al.
Publicado: (2020)

Recent Advances in Nanoplatforms for the Treatment of Osteosarcoma
por: Wu, Kunzhe, et al.
Publicado: (2022)

Glycol chitosan nanoparticles as specialized cancer therapeutic vehicles: Sequential delivery of doxorubicin and Bcl-2 siRNA
por: Yoon, Hong Yeol, et al.
Publicado: (2014)

Novel polymer micelle mediated co-delivery of doxorubicin and P-glycoprotein siRNA for reversal of multidrug resistance and synergistic tumor therapy
por: Zhang, Chun-ge, et al.
Publicado: (2016)

Protection and Systemic Translocation of siRNA Following Oral Administration of Chitosan/siRNA Nanoparticles
por: Ballarín-González, Borja, et al.
Publicado: (2013)

Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted PEGylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance
por: Haghiralsadat, Fateme, et al.
Publicado: (2018)

Doxorubicin and Edelfosine Combo-Loaded Lipid–Polymer Hybrid Nanoparticles for Synergistic Anticancer Effect Against Drug-Resistant Osteosarcoma
por: Yang, Ping, et al.
Publicado: (2020)

Doxorubicin combined with Notch1-targeting siRNA for the treatment of gastric cancer
por: Zhou, Wei, et al.
Publicado: (2018)

Conjugation of Doxorubicin to siRNA Through Disulfide-based Self-immolative Linkers
por: Gauthier, Florian, et al.
Publicado: (2020)

Antitumorigenic Effect of Tramadol and Synergistic Effect With Doxorubicin in Human Breast Cancer Cells
por: Huang, Yi-Hsuan, et al.
Publicado: (2022)

Codelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticles-polymerpolyethylenimine to improve oral squamous carcinoma treatment
por: Wang, Dandan, et al.
Publicado: (2017)

Synergistic Effect of Doxorubicin and siRNA-Mediated Silencing of Mcl-1 Using Cationic Niosomes against 3D MCF-7 Spheroids
por: Pengnam, Supusson, et al.
Publicado: (2021)

Albumin pre-coating enhances intracellular siRNA delivery of multifunctional amphiphile/siRNA nanoparticles
por: Kummitha, China M, et al.
Publicado: (2012)

Advances in Lipid Nanoparticles for siRNA Delivery
por: Tam, Yuen Yi C., et al.
Publicado: (2013)

BSA Nanoparticles for siRNA Delivery: Coating Effects on Nanoparticle Properties, Plasma Protein Adsorption, and In Vitro siRNA Delivery
por: Yogasundaram, Haran, et al.
Publicado: (2012)

Hybrid Cell Membrane-Functionalized Biomimetic Nanoparticles for Targeted Therapy of Osteosarcoma
por: Cai, Jia-Xin, et al.
Publicado: (2022)

PYGB siRNA inhibits the cell proliferation of human osteosarcoma cell lines
por: Zhang, Shuwei, et al.
Publicado: (2018)

Novel siRNA formulation to effectively knockdown mutant p53 in osteosarcoma
por: Kundu, Anup K., et al.
Publicado: (2017)

Galactosylated Liposomes for Targeted Co-Delivery of Doxorubicin/Vimentin siRNA to Hepatocellular Carcinoma
por: Oh, Hea Ry, et al.
Publicado: (2016)

Biomimetic Nanoparticles Camouflaged in Cancer Cell Membranes and Their Applications in Cancer Theranostics
por: Jin, Jiefu, et al.
Publicado: (2020)

Biomimetic CuS nanoparticles for radiosensitization with mild photothermal therapy and GSH-depletion
por: Zhou, Xiaoxiang, et al.
Publicado: (2022)

Photostable and Biocompatible Fluorescent Silicon Nanoparticles for Imaging-Guided Co-Delivery of siRNA and Doxorubicin to Drug-Resistant Cancer Cells
por: Guo, Daoxia, et al.
Publicado: (2019)

Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer
por: Zhuang, Jialang, et al.
Publicado: (2021)

Codelivery of Doxorubicin and MDR1-siRNA by Mesoporous Silica Nanoparticles-Polymerpolyethylenimine to Improve Oral Squamous Carcinoma Treatment [Corrigendum]
Publicado: (2021)

Sorafenib and Doxorubicin Show Synergistic Effects in Human and Canine Osteosarcoma Cell Lines
por: Yang, Ya-Ting, et al.
Publicado: (2022)

Injectable agarose hydrogels and doxorubicin-encapsulated iron-gallic acid nanoparticles for chemodynamic-photothermal synergistic therapy against osteosarcoma
por: Ying, Hongliang, et al.
Publicado: (2022)

Intracellular Delivery of siRNA by Polycationic Superparamagnetic Nanoparticles
por: Castillo, Betzaida, et al.
Publicado: (2012)

ECO/siRNA nanoparticles and breast cancer metastasis
por: Lu, Zheng-Rong, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8qgc6rdh6gn3f1lp7skk17le6m